Development Technologies is trading at 5.00 as of the 29th of December 2025, a No Change since the beginning of the trading day. The stock's open price was 5.0. Development Technologies has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 29th of November 2025 and ending today, the 29th of December 2025. Click here to learn more.
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida. Development Technologies operates under Shell Companies classification in the United States and is traded on OTC Exchange.. More on Development Technologies Corp
Our tools can tell you how much better you can do entering a position in Development Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio File Import Now
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Other Information on Investing in Development Pink Sheet
Development Technologies financial ratios help investors to determine whether Development Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Development with respect to the benefits of owning Development Technologies security.